Medicinova Inc (NASDAQ:MNOV)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $920K
- Net income
- -$10.8M
- Net margin
- -1168.2%
Little or no net debt.
- Total debt
- $117K
- Cash
- $25.4M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $25.9M
- Current liabilities
- $3.0M
- Current ratio
- 8.75
Consumes cash and must keep raising it.
- Operating cash flow
- -$1.93B
- Free cash flow
- -$1.93B
- FCF margin
- -209374.2%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 49.2M
- Share growth (1y)
- 0.4%
- Cash runway
- 0 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MNOV Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 458.44 K | 186.98 K | 151.74 K | 123.32 K | 134.60 K | 0.00 |
| Revenue Growth (YoY) | 240.60 % | — | — | — | — | — |
| Cost of Revenue | 140.68 K | 174.36 K | 99.98 K | 115.27 K | 116.35 K | 0.00 |
| Gross Profit | 317.76 K | 12.62 K | 51.76 K | 8.05 K | 18.25 K | 0.00 |
| SG&A Expense | 1.83 M | 1.59 B | 1.55 M | 1.81 M | 1.44 M | 1.36 M |
| R&D Expense | 1.03 M | 1.26 B | 1.69 M | 1.52 M | 2.04 M | 1.74 M |
| Operating Expenses | 2.86 M | 2.85 M | 3.14 M | 3.39 M | 3.63 M | 3.20 M |
| Operating Income | -2.54 M | -2.84 M | -3.09 M | -3.38 M | -3.61 M | -3.20 M |
| Pretax Income | -2.31 M | -2.59 M | -2.80 M | -3.05 M | -3.28 M | -2.86 M |
| Tax Provision | 0.00 | 0.00 | 5.99 K | 0.00 | 0.00 | 0.00 |
| Net Income | -2.31 M | -2.59 M | -2.80 M | -3.05 M | -3.28 M | -2.86 M |
| EPS (Basic) | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 | -0.06 |
| EPS (Diluted) | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 | -0.06 |
| Shares Outstanding | 49.22 M | 49.22 M | 49.06 M | 49.05 M | 49.05 M | 49.05 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.